K. Didier, A. Robbins, F. Antonicelli, B. N. Pham, D. Giusti et al., Actualités dans la physiopathologie de la sclérodermie systémique : vers de nouvelles opportunités thérapeutiques, Rev Med Interne, vol.40, pp.654-663, 2019.

M. Elhai, C. Meune, J. Avouac, A. Kahan, and Y. Allanore, Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies, Rheumatol (Oxford), vol.51, pp.1017-1043, 2012.

M. Elhai, J. Avouac, A. Kahan, and Y. Allanore, Systemic sclerosis: Recent insights, Joint Bone Spine, vol.82, pp.148-53, 2015.

M. Michaud, F. Catros, S. Ancellin, and F. Gaches, Mise au point sur les sclérodermies très précoces et précoces, Rev Med Interne, vol.40, pp.517-522, 2019.

A. J. Tyndall, B. Bannert, M. Vonk, P. Airò, F. Cozzi et al., Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database, Ann Rheum Dis, vol.69, pp.1809-1824, 2010.

S. Systémique, Protocole National de Diagnostic et de Soins, 2017.

E. C. Leroy, C. Black, R. Fleischmajer, S. Jablonska, T. Krieg et al.,

, Scleroderma (systemic sclerosis): classification, subsets and pathogenesis, J Rheumatol, vol.15, pp.202-207, 1988.

F. Van-den-hoogen, D. Khanna, J. Fransen, S. R. Johnson, M. Baron et al., 2013 classification criteria for systemic sclerosis: an American College of

. Rheumatology/european, League against Rheumatism collaborative initiative, Arthritis Rheum, vol.65, pp.2737-2784, 2013.

G. Ngian, J. Sahhar, and I. P. Wicks, Van Doornum S. Cardiovascular disease in systemic

A. Psarras, S. Soulaidopoulos, A. Garyfallos, G. Kitas, and T. Dimitroulas, A critical view on cardiovascular risk in systemic sclerosis, Rheumatol Int, vol.37, pp.85-95, 2017.

U. Nussinovitch and Y. Shoenfeld, Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality, Autoimmun Rev, vol.10, pp.259-66, 2011.

M. E. Hettema, D. Zhang, K. De-leeuw, Y. Stienstra, A. J. Smit et al., Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors, Arthritis Res Ther, vol.10, p.49, 2008.

C. T. Derk, M. Rasheed, C. M. Artlett, and S. A. Jimenez, A cohort study of cancer incidence in systemic sclerosis, J Rheumatol, vol.33, pp.1113-1119, 2006.

A. Onishi, D. Sugiyama, S. Kumagai, and A. Morinobu, Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies, Arthritis Rheum, vol.65, pp.1913-1934, 2013.

É. Szekanecz, S. Szamosi, Á. Horváth, Á. Németh, B. Juhász et al., Malignancies associated with systemic sclerosis, Autoimmun Rev, vol.11, pp.852-857, 2012.

T. Igusa, L. K. Hummers, K. Visvanathan, C. Richardson, F. M. Wigley et al., Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer, Ann Rheum Dis, vol.77, pp.1179-1186, 2018.